Literature DB >> 18237553

Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and/or oxidative stress?

Solange C Garcia1, Angela T S Wyse, Juliana Valentini, Miguel Roehrs, Angela M Moro, Clóvis Paniz, Gabriela Schmitt, Denise Grotto, Valdeci J Pomblum.   

Abstract

OBJECTIVES: To quantify serum butyrylcholinesterase activity in haemodialysis patients and to evaluate if the homocysteine levels and/or oxidative stress biomarkers have an effect on butyrylcholinesterase.
MATERIALS AND METHODS: Blood samples were collected from patients and healthy subjects (control). The plasma homocysteine and TBARS levels; serum butyrylcholinesterase activity; blood delta aminolevulinic acid dehydratase (ALA-D) activity and methahaemoglobin were analyzed. The mortality of the patients was also evaluated after 3 years.
RESULTS: The homocysteine was increased and butyrylcholinesterase decreased compared to control (p<0.05). TBARS and methahaemoglobin were increased and ALA-D decreased (p<0.05). The following correlations were found: homocysteine with butyrylcholinesterase (-0.44); methahaemoglobin (0.41); ALA-D (-0.68); and TBARS (0.66). The partial correlation between homocysteine with butyrylcholinesterase, withdrawn the effect of TBARS, was -0.30; all p<0.05. Moreover, it was observed that 22% of the patients died due to cardiovascular problems.
CONCLUSION: Thus, our findings support a direct association between the reduction of butyrylcholinesterase by the increase of homocysteine and an indirect effect by increase in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18237553     DOI: 10.1016/j.clinbiochem.2008.01.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis patients.

Authors:  Tanja Antunovic; Aleksandra Stefanovic; Marina Ratkovic; Branka Gledovic; Najdana Gligorovic-Barhanovic; Dragica Bozovic; Jasmina Ivanisevic; Milica Prostran; Marina Stojanov
Journal:  Int Urol Nephrol       Date:  2012-07-25       Impact factor: 2.370

2.  Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Authors:  Teppei Okamoto; Chikako Tsutaya; Shingo Hatakeyama; Sakae Konishi; Kazutaka Okita; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

3.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.